People with HIV taking newer antiretrovirals at higher risk of fatty liver disease

People with HIV were more likely to develop fatty liver disease if they took antiretroviral treatment that contains an integrase inhibitor or tenofovir alafenamide (TAF), a German research group has found. Non-alcoholic fatty liver disease (NAFLD) develops through accumulation of fat in the liver. People with diabetes and / or high body mass are more… Read More »

A new risk factor for ‘breakthrough’ Covid infection in fully vaccinated has been found

COVID-19 is an unpredictable virus: some people catch it and are asymptomatic. Others, on the other hand, can end up in hospital. The Covid vaccines deployed against the viral disease have made it far less unpredictable by making it less severe. Despite the palpable benefits of getting vaccinated, breakthrough Covid infections have cropped in fully… Read More »

Is COVID a turning point for sustainability in hospital supply chains? [PODCAST]

“Scarcity has, in many ways, defined the COVID-19 experience in the U.S., from shortages in personal protective equipment to ICU ventilators and hospital capacity, to COVID test kits, to drugs like Remdesivir in hard-hit states. These shortages have added impetus and new dimensions to existing conversations around health care supply chains, some of which had… Read More »